In addition to being prone to hyponatraemia, patients with these conditions often experience potassium abnormalities, including hyperkalaemia and hypokalaemia, due to the use of renin–angiotensin system inhibitors and potassium-wasting diuretics [28]. This evidence concerns the gene REN and Hyperkalemia.